APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $284,961 | +27.9% | 3,128 | -7.4% | 0.16% | +19.6% |
| Q1 2023 | $222,813 | -24.7% | 3,378 | -41.0% | 0.14% | -31.7% |
| Q4 2022 | $296,040 | -89.5% | 5,725 | -86.2% | 0.20% | -89.6% |
| Q3 2022 | $2,825,000 | +769.2% | 41,365 | +476.2% | 1.94% | +742.0% |
| Q2 2022 | $325,000 | -7.1% | 7,179 | +4.4% | 0.23% | +4.1% |
| Q1 2022 | $350,000 | -38.6% | 6,879 | -43.0% | 0.22% | -36.6% |
| Q4 2021 | $570,000 | +172.7% | 12,060 | +264.4% | 0.35% | +171.3% |
| Q2 2021 | $209,000 | -11.8% | 3,310 | -40.1% | 0.13% | -15.7% |
| Q1 2021 | $237,000 | -27.5% | 5,523 | -3.4% | 0.15% | -31.7% |
| Q4 2020 | $327,000 | – | 5,718 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |